Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

Blog

Displaying 1 to 10 of 93 Posts . Displaying 10 of Posts . Page of 10 . Go To Page: . Per Page: . . . View All Sort By: .

Commentary: Genetic studies suggest that inflammatory skin diseases increase the risk of COVID-19.

Professor Francesca Capon provides a commentary An article recently published in the Journal of Allergy and Clinical Immunology1 suggests that diseases such as psoriasis and atopic dermatitis increase the risk of COVID-19 by approximately 50%.

Read More

In the Lab with IPC Councilor Nicole Ward

Dr. Ward is a Professor of Dermatology and Neurosciences at Case Western Reserve University and University Hospitals Case Medical Center in Cleveland, Ohio. She has spent the past 16 years developing mouse models to help identify the cellular and molecular mechanisms underlying inflammatory skin disease and its associated comorbidities.

Read More

Commentary: Cytokine inhibitors have a low prevalence of SARS-CoV-2 seroconversion

n a recent publication in Nature Communications1 a team from Friedrich-Alexander University in Germany described their findings from a cross-sectional population cohort study on the prevalence of anti-SARS-CoV-2 immunoglobulin G (IgG) in patients with chronic immune-mediated inflammatory diseases (IMIDs) on cytokine-blocking treatments. This patient cohort was compared against subjects with IMIDs, not on cytokine inhibitors, health care workers, and healthy controls. The findings from this study showed that patients with IMID on cytokine inhibitors had a lower prevalence of anti-SARS-CoV-2 IgG response compared to the other three cohorts. To assess whether this could be accounted for by differences in social exposure between the groups, the investigators assessed exposure risk variables in the four groups and found those to be similar between the two IMID groups and less than that of health care workers.

Read More

Introducing the IPC Academy Online

IPC Academy Online, a free online learning platform, has been designed to provide expert insight, timely research, and practical information to dermatologists anywhere in the world to improve the care of psoriasis patients.

Read More

2020 Virtual Think Tank Meeting Report

Held virtually on December 11 due to the Coronavirus Pandemic, the 2020 IPC Think Tank convened more than 100 specialists in psoriasis and industry partners from all over the world to discuss the most pressing issues affecting psoriasis care and treatment globally. The outcome of these discussions will inform IPC initiatives in 2021 and beyond.

Read More

Commentary: NPF COVID-19 Task Force Guidance Statements

Recently, the Task Force (TF) of the National Psoriasis Foundation (NPF) released a revised version of its COVID-19 statement after an in-depth analysis of publicly available data with two currently approved anti-SARS-CoV-2 vaccines in the US, both mRNA-based.

Read More

IPC Statement on SARS-CoV-2 Vaccines and Psoriasis

While the news of a potential SARS-CoV-2 vaccine is to be welcomed, the impact of psoriasis therapy, particularly systemic therapy, on the effectiveness and safety of vaccines needs to be considered.

Read More

Psoriasis updates in a nutshell: Pathogenesis, markers and therapeutics

Get the latest updates about psoriasis on topics such as pathogenesis, markers and therapeutics from Dr. Mohamed El-Komy in this short IPC video.

Read More

Are you a dermatologist practicing in the Middle East?

Get the latest news on treating psoriasis in the Middle East with Dr. El Sayed.

Read More

Common clinical tools to assess psoriasis severity may not capture full impact of disease

The IPC Disease Severity Working Group concluded that the objective measures of two commonly used clinical tools to determine psoriasis severity may not fully capture the impact of the disease on the individual in a new review published in the Journal of The Academy of Dermatology and Venerology (JEADV).

Read More

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.
SUBSCRIBE

now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now

Search Our Blog

  Search
 

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK